Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Divestments (2023 - 2024)

Historic Divestments for Angiodynamics (ANGO) over the last 6 years, with Q1 2024 value amounting to $34.5 million.

  • Angiodynamics' Divestments changed N/A to $34.5 million in Q1 2024 from the same period last year, while for Nov 2024 it was $34.5 million, marking a year-over-year decrease of 6550.0%. This contributed to the annual value of $134.5 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2024, Angiodynamics' Divestments is $34.5 million.
  • In the past 5 years, Angiodynamics' Divestments ranged from a high of $100.0 million in Q3 2023 and a low of $34.5 million during Q1 2024